Citation: B. Nyholm et al., Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus, EXPERT OP I, 10(9), 2001, pp. 1641-1652
Authors:
Gravholt, CH
Nyholm, B
Saltin, B
Schmitz, O
Christiansen, JS
Citation: Ch. Gravholt et al., Muscle fiber composition and capillary density in Turner syndrome - Evidence of increased muscle fiber size related to insulin resistance, DIABET CARE, 24(9), 2001, pp. 1668-1673
Authors:
Orskov, L
Schmitz, O
Bak, JF
Lund, S
Kaal, A
Nyholm, B
Moller, N
Citation: L. Orskov et al., Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects, SC J CL INV, 61(5), 2001, pp. 371-381
Authors:
Jorgensen, TOL
Rosenfalck, AM
Fisker, S
Nyholm, B
Fineman, MS
Schmitz, O
Madsbad, S
Holst, JJ
Christiansen, JS
Citation: Tol. Jorgensen et al., Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study, EUR J ENDOC, 143(5), 2000, pp. 593-599
Authors:
Nyholm, B
Porksen, N
Juhl, CB
Gravholt, CH
Butler, PC
Weeke, J
Veldhuis, JD
Pincus, S
Schmitz, O
Citation: B. Nyholm et al., Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: Evidence of early beta-cell dysfunction, METABOLISM, 49(7), 2000, pp. 896-905
Authors:
Nielsen, MF
Nyholm, B
Caumo, A
Chandramouli, V
Schumann, WC
Cobelli, C
Landan, BR
Rizza, RA
Schmitz, O
Citation: Mf. Nielsen et al., Prandial glucose effectiveness and pasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes, DIABETES, 49(12), 2000, pp. 2135-2141
Authors:
Nyholm, B
Ostergard, T
Vaag, A
Schmitz, O
Citation: B. Nyholm et al., What have metabolic studies in healthy relatives taught us about the pathogenesis of Type 2 diabetes, DIABETES ANNUAL/13, 2000, pp. 175-200
Authors:
Orskov, L
Nyholm, B
Hove, KY
Gravholt, CH
Moller, N
Schmitz, O
Citation: L. Orskov et al., Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects, DIABET MED, 16(10), 1999, pp. 867-874
Authors:
Nyholm, B
Orskov, L
Hove, KY
Gravholt, CH
Moller, N
Alberti, KGMM
Moyses, C
Kolterman, O
Schmitz, O
Citation: B. Nyholm et al., The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus, METABOLISM, 48(7), 1999, pp. 935-941
Authors:
Nyholm, B
Walker, M
Gravholt, CH
Shearing, PA
Sturis, J
Alberti, KGMM
Holst, JJ
Schmitz, O
Citation: B. Nyholm et al., Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations, DIABETOLOG, 42(11), 1999, pp. 1314-1323